Maven Securities LTD Charles River Laboratories International, Inc. Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $912,968 - $1.12 Million	-2,450 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $458,905 - $579,774	-1,560 Reduced 38.9%	2,450 $904,000
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $996,183 - $1.19 Million	-3,990 Reduced 49.88%	4,010 $1.18 Million
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $1.55 Million - $1.77 Million	7,000 Added 700.0%	8,000 $2 Million
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $175,560 - $226,450	1,000 New	1,000 $227,000

732

51.8M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.81B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.